Abstract
Several well controlled epidemiologic and hemodynamic studies suggest that about 20% of sleep apnea syndrome (SAS) patients will have chronic obstructive pulmonary disease (COPD), and the majority of these patients (with combined diseases) will have pulmonary hypertension. Indeed it has been suggested that only patients with underlying hypoxemia, such as that from COPD, will develop right heart failure in the OSA setting. Experience shows that apnea/COPD patients will have severe hypersomnolence associated with the OSA, cough and dyspnea with the airways disease, and edema and plethora related to chronic hypoxemia. Many patients present with respiratory failure and are diagnosed at the time of initial intubation and mechanical ventilation. Episodic nocturnal hypoxemia may be worsened by a steeper rate of desaturation due to lower alveolar and blood oxygen stores, and longer apneas perhaps contributed to by depressed chemosensitivity. Daytime hypoxemia may also add to the severe hemodynamic disturbances. Since COPD cannot be cured, aggressive treatment of SAS is critical. Past studies have shown that tracheostomy or nasal CPAP in this setting not only leads to resolution of episodic nocturnal desaturation but may lead to rapid improvement in daytime oxygenation in many patients. Pulmonary hypertension and other measures of cardiopulmonary function improve when apnea is cured. Elimination of the SAS may disclose nonapneic REM related desaturation that could require supplemental oxygen therapy in addition to tracheostomy or nasal CPAP. Pulmonary function testing in SAS patients with smoking histories, followed by aggressive treatment of SAS, is recommended.
Similar content being viewed by others
References
Hensley JJ, Read DJC (1976) Intermittent obstruction of the upper airway during sleep causing profound hypoxemia. A neglected mechanism exacerbating chronic respiratory failure. Aust N Z J Med 6:481–486
Aubert-Tulkens G, Willems B, Veriter C et al (1980) Increase in ventilatory response to CO2 following tracheostomy in obstructive sleep apnea. Bull Eur Physiopathol Respir 16:587–593
Kearley R, Wynne JW, Block AJ, et al. (1980) The effect of low flow oxygen on sleep disordered breathing and oxygen desaturation. Chest 78:683–685
Goldstein RS, Ramcharan V, Bowes G, et al (1984) Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med 310:425–429
Sullivan CE, Berthon-Jones M, Issa FG (1983) Remission of severe obesity-hypoventilation syndrome after short-term treatment during sleep with nasal continuous positive airway pressure. Am Rev Respir Dis 128:177–181
Guilleminault C, Cummiskey J, Motta J (1980) Chronic obstructive airflow disease and sleep studies. Am Rev Respir Dis 122:397–406
Fletcher EC, Brown D (1985) Nocturnal oxyhemoglobin desaturation following tracheostomy for obstructive sleep apnea. Am J Med 79:35–41
Alford NJ, Fletcher EC, Nickeson D (1986) Acute oxygen in patients with sleep apnea and COPD. Chest 89:30–38
Fletcher EC, Schaaf JW, Miller J, Fletcher JG (1987) Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Rev Respir Dis 135:525–533
Fletcher EC (1987) Interaction of sleep apnea and chronic lung disease. In: Peter JH, Podszus T, Von Wichert P, eds. Sleep Related Disorders and Internal Diseases. Berlin: Springer-Verlag, 289
Ashutosh K, Mead G, Dunsky M (1983) Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and cor pulmonale. Am Rev Respir Dis 127:399–404
Bradley TD, Rutherford R, Grossman RF, et al (1985) Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 131:835–839
Weitzenblum E, Krieger J, Apprill M, Vallee E, Ehrhart M, Ratomaharo J, Oswald M, and Kurtz D (1988) Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 138:345–349
Emirgil C, Sobol BJ (1973) The effects of weight reduction on pulmonary function and the sensitivity of the respiratory center in obesity. Am Rev Respir Dis 108:831–842
Holley HS, Milic-Emili J, Becklake MR, et al (1967) Regional distribution of pulmonary ventilation and perfusion in obesity. J Clin Invest 46:475–481
Findley LJ, Wilhoit SC, Suratt PM (1985) Apnea duration and hypoxemia during REM sleep in patients with obstructive sleep apnea. Chest 87:432–435
Findley LJ, Ries AL, Tisi GM, Wagner PD (1983) Hypoxemia during apnea in normal subjects: mechanisms and impact of lung volume. J Appl Physiol 55:1777–1783
Shepard JW (1985) Gas exchange and hemodynamics during sleep. In: Medical clinics of North America, symposium on sleep apnea disorders. 69:1243–1264
Bradley TD, Martinez D, Rutherford R, Lue F, Grossman R, Moldofsky H, Zamel N, Phillipson EA (1985) Physiological determinants of nocturnal arterial oxygenation in patients with obstructive sleep apnea. J Appl Physiol 59:1364–68
Strohl KP, Altose MD (1984) Oxygen saturation during breath-holding and during apneas in sleep. Chest 85:181–186
Cherniack NS, Longobardo GS (1970) Oxygen and carbon dioxide gas stores of the body. Physiol Rev 50:196–243
Fletcher EC, Kass R, Thornby JI, Rosborough J, Miller T (1989) Central venous O2 saturation and rate of arterial desaturation during obstructive apnea. J Appl Physiol 66(3):1477–1485
Fletcher EC, Costarangos C, Miller T (1989) The rate of fall of arterial oxyhemoglobin saturation in obstructive sleep apnea. Chest 96:717–722
Fletcher EC, Goodnight S, Miller T, Rosborough J, Luckett R, Munafo DA, Muniz S (1989) Pulmonary gas exchange and the rate of arterial oxygen desaturation in obstructive apnea. Am Rev Respir Dis 139:A180
O’Connell JM, Campbell AH (1976) Respiratory mechanics in airways obstruction associated with inspiratory dyspnoea. Thorax 31:669–677
Rochester DF, Braun NMT, Arora NS (1979) Respiratory muscle strength in chronic obstructive pulmonary disease. Am Rev Respir Dis 119:151–154
Ashutosh K, Gilbert R, Auchincloss JH Jr, Peppi D (1975) Asynchronous breathing movements in patients with chronic obstructive pulmonary disease. Chest 67:553–557
Jardim J, Farkas G, Prefaut C, et al (1981) The failing inspiratory muscles under normoxic and hypoxic conditions. Am Rev Respir Dis 124:274–279
Fritts HW Jr, Filler J, Fishmann AP, Cournand A (1959) The efficiency of ventilation during voluntary hyperpnea: studies in normal subjects and in dyspneic patients with either chronic pulmonary emphysema or obesity. J Clin Invest 38:1339–1348
Rochester DF, Enson Y (1974) Current concepts in the pathogenesis of the obesity-hypoventilation syndrome. Am J Med 57:402–420
Staats BA, Bonekat HW, Harris CD, Offord KP (1984) Chest wall motion in sleep apnea. Am Rev Respir Dis 130:59–60
Fletcher EC (1986) Chronic lung disease in patients with sleep apnea. In: Fletcher EC, ed. Abnormalities of Respiration During Sleep: Diagnosis, Pathophysiology, and Treatment. Orlando: Grune and Stratton, Inc, pp 181–202
Sullivan CE, Issa FG (1980) Pathophysiological mechanisms in obstructive sleep apnea. Sleep 3:235–246
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fletcher, E.C. Chronic lung disease in the sleep apnea syndrome. Lung 168 (Suppl 1), 751–761 (1990). https://doi.org/10.1007/BF02718204
Issue Date:
DOI: https://doi.org/10.1007/BF02718204